Literature DB >> 24077847

Age effects on extracellular matrix production of vocal fold scar fibroblasts in rats.

Markus Gugatschka, Herwig Ainödhofer, Hans-Jürgen Gruber, Matthias Graupp, Petra Kieslinger, Karl Kiesler, Amulya Saxena, Shigeru Hirano, Gerhard Friedrich.   

Abstract

Vocal fold (VF) fibroblasts are the central subject of interest in fibrogenesis and wound healing after VF injury. Scar fibroblasts (SF) exhibit an aberrant production of several extracellular matrix (ECM) components which lead either to VF fibrosis or scarless wound healing. This study aimed to investigate the role of age at the time of injury on ECM production of SF. This is designed as an animal study. VF injury was established unilaterally in eight male Sprague-Dawley rats [3 months of age (n = 4), 11 months of age (n = 4)], while the other side was left intact. Three months after injury the larynges were excised and fibroblasts were extracted from VF [normal fibroblasts (NF)–scar fibroblasts (SF)] and cultured in vitro. After first passage, VF fibroblasts were plated in 24-well plates and levels of hyaluronic acid (HA) and collagen type I were determined enzymatically from supernatant after 24 and 72 h. Cultured SF from younger animals produced significantly higher levels of HA compared to NF fibroblasts from the same animals. HA concentrations of the older animals did not differ significantly between the NF and SF cultures, but the range in SF cultures was large. In contrast to previous studies, we found that even 3 months after VF injury cultured SF from young animals expressed higher levels of HA in comparison to SF from older animals. No difference in collagen levels were observed between the younger and older animals. Age of animals is an essential factor during VF healing and has to be considered for study design.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24077847     DOI: 10.1007/s00405-013-2722-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  22 in total

Review 1.  Current treatment of vocal fold scarring.

Authors:  Shigeru Hirano
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2005-06       Impact factor: 2.064

2.  The Scar-in-a-Jar: studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well.

Authors:  C Z C Chen; Y X Peng; Z B Wang; P V Fish; J L Kaar; R R Koepsel; A J Russell; R R Lareu; M Raghunath
Journal:  Br J Pharmacol       Date:  2009-09-28       Impact factor: 8.739

3.  Characterization of vocal fold scarring in a canine model.

Authors:  Bernard Rousseau; Shigeru Hirano; Troy D Scheidt; Nathan V Welham; Susan L Thibeault; Roger W Chan; Diane M Bless
Journal:  Laryngoscope       Date:  2003-04       Impact factor: 3.325

4.  Recruitment patterns of side population cells during wound healing in rat vocal folds.

Authors:  Markus Gugatschka; Tsuyoshi Kojima; Satoshi Ohno; Shin-ichi Kanemaru; Shigeru Hirano
Journal:  Laryngoscope       Date:  2011-08       Impact factor: 3.325

5.  A rat excised larynx model of vocal fold scar.

Authors:  Nathan V Welham; Douglas W Montequin; Ichiro Tateya; Tomoko Tateya; Seong Hee Choi; Diane M Bless
Journal:  J Speech Lang Hear Res       Date:  2009-08       Impact factor: 2.297

6.  Cell production in injured vocal folds: a rat study.

Authors:  Ichiro Tateya; Tomoko Tateya; Xinhong Lim; Jin Ho Sohn; Diane M Bless
Journal:  Ann Otol Rhinol Laryngol       Date:  2006-02       Impact factor: 1.547

Review 7.  Influence of age on wound healing and fibrosis.

Authors:  Maria G Kapetanaki; Ana L Mora; Mauricio Rojas
Journal:  J Pathol       Date:  2013-01       Impact factor: 7.996

8.  Effects of matrix composition, microstructure, and viscoelasticity on the behaviors of vocal fold fibroblasts cultured in three-dimensional hydrogel networks.

Authors:  Alexandra J E Farran; Sean S Teller; Amit K Jha; Tong Jiao; Rohan A Hule; Rodney J Clifton; Darrin P Pochan; Randall L Duncan; Xinqiao Jia
Journal:  Tissue Eng Part A       Date:  2010-04       Impact factor: 3.845

9.  Morphological and extracellular matrix changes following vocal fold injury in mice.

Authors:  Masaru Yamashita; Diane M Bless; Nathan V Welham
Journal:  Cells Tissues Organs       Date:  2010-05-27       Impact factor: 2.481

10.  Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis state of the art.

Authors:  Clarice Zc Chen; Michael Raghunath
Journal:  Fibrogenesis Tissue Repair       Date:  2009-12-15
View more
  6 in total

Review 1.  The unsolved chapter of vocal fold scars and how tissue engineering could help us solve the problem.

Authors:  M Graupp; S Bachna-Rotter; C Gerstenberger; G Friedrich; E Fröhlich-Sorger; K Kiesler; M Gugatschka
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-25       Impact factor: 2.503

Review 2.  MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment.

Authors:  Yan Li; Juan Zhang; Yuying Lei; Lechun Lyu; Ruiling Zuo; Ting Chen
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

3.  Vocal fold myofibroblast profile of scarring.

Authors:  Anete Branco; Stephanie M Bartley; Suzanne N King; Marie E Jetté; Susan L Thibeault
Journal:  Laryngoscope       Date:  2015-09-07       Impact factor: 3.325

4.  Development and validation of a novel phonomimetic bioreactor.

Authors:  Andrijana Kirsch; David Hortobagyi; Theresa Stachl; Michael Karbiener; Tanja Grossmann; Claus Gerstenberger; Markus Gugatschka
Journal:  PLoS One       Date:  2019-03-14       Impact factor: 3.240

5.  Reversal of Vocal Fold Mucosal Fibrosis Using siRNA against the Collagen-Specific Chaperone Serpinh1.

Authors:  Yo Kishimoto; Masaru Yamashita; Alice Wei; Yutaka Toya; Shuyun Ye; Christina Kendziorski; Nathan V Welham
Journal:  Mol Ther Nucleic Acids       Date:  2019-04-22       Impact factor: 8.886

Review 6.  [Molecular laryngology : A new chapter in the understanding of laryngeal diseases].

Authors:  M Gugatschka; T Grossmann; D Hortobagyi
Journal:  HNO       Date:  2021-04-06       Impact factor: 1.284

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.